Literature DB >> 6934029

Cytofluorescence localization of anthracycline antibiotics.

M J Egorin, R E Clawson, J L Cohen, L A Ross, N R Bachur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6934029

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  13 in total

1.  Fluorescent cationic probes for nuclei of living cells: why are they selective? A quantitative structure-activity relations analysis.

Authors:  Richard W Horobin; Juan C Stockert; Fiza Rashid-Doubell
Journal:  Histochem Cell Biol       Date:  2006-02-07       Impact factor: 4.304

2.  Cellular pharmacology and antitumor activity of N-(p-azidobenzoyl)-daunorubicin, a photoactive anthracycline analogue.

Authors:  S D Averbuch; R E Clawson; N R Bachur; R L Felsted
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies.

Authors:  Kunio Fujiwara; Masashi Shin; David M Hougaard; Lars-Inge Larsson
Journal:  Histochem Cell Biol       Date:  2006-07-19       Impact factor: 4.304

4.  Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia.

Authors:  C Mazurek; J P Dutcher; E L Schwartz; S Garl; L Benson; P H Wiernik
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850

5.  Cytofluorescence localization of adriamycin in resistant colon cancer cells.

Authors:  B Chauffert; F Martin; A Caignard; J F Jeannin; A Leclerc
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients.

Authors:  P A Speth; P C Linssen; J B Boezeman; H M Wessels; C Haanen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 7.  Anthracycline antibiotics in cancer therapy. Focus on drug resistance.

Authors:  D J Booser; G N Hortobagyi
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

8.  Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro.

Authors:  Rosemary A Ndolo; Yepeng Luan; Shaofeng Duan; M Laird Forrest; Jeffrey P Krise
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Improved immunocytochemical detection of daunomycin.

Authors:  Koji Ohara; Masashi Shin; Lars-Inge Larsson; Kunio Fujiwara
Journal:  Histochem Cell Biol       Date:  2007-01-25       Impact factor: 2.531

10.  Visualisation of doxorubicin in human and animal tissues and in cell cultures by immunogold-silver staining.

Authors:  H P Henneberry; G W Aherne
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.